Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
K-877 ER vs IR in Dyslipidemia with High Triglycerides
NCT04714151Phase 3Completed
- Sponsor
- Kowa Company, Ltd.
- Start
- Feb 2021
- Primary completion
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of pemafibrate in hypertriglyceridemia, sponsored by Kowa Company, Ltd.. Started Feb 2021; status: completed.
02
Drugs
pemafibrate
03
Conditions
hypertriglyceridemia
Beyond the preview
Go deeper on NCT04714151.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04714151.